These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 31948925)
1. Gastric Intestinal Metaplasia (GIM): Clinical Decision Support Tool. American Gastroenterological Association Gastroenterology; 2020 Feb; 158(3):703. PubMed ID: 31948925 [No Abstract] [Full Text] [Related]
2. Spotlight: Gastric Intestinal Metaplasia. Shah SC; Gupta S; Li D; Morgan D; Mustafa RA; Gawron AJ Gastroenterology; 2020 Feb; 158(3):704. PubMed ID: 32035529 [No Abstract] [Full Text] [Related]
3. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gupta S; Li D; El Serag HB; Davitkov P; Altayar O; Sultan S; Falck-Ytter Y; Mustafa RA Gastroenterology; 2020 Feb; 158(3):693-702. PubMed ID: 31816298 [No Abstract] [Full Text] [Related]
4. Gastric cancer prevention from the point of Helicobacter. Balaban YH; Simşek H; Tatar G Turk J Gastroenterol; 2014 Aug; 25(4):463-7. PubMed ID: 25254545 [No Abstract] [Full Text] [Related]
5. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gawron AJ; Shah SC; Altayar O; Davitkov P; Morgan D; Turner K; Mustafa RA Gastroenterology; 2020 Feb; 158(3):705-731.e5. PubMed ID: 31816300 [No Abstract] [Full Text] [Related]
6. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Shah SC; Gawron AJ; Mustafa RA; Piazuelo MB Gastroenterology; 2020 Feb; 158(3):745-750. PubMed ID: 31887261 [No Abstract] [Full Text] [Related]
7. The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines. Dinis-Ribeiro M; Shah S; El-Serag H; Banks M; Uedo N; Tajiri H; Coelho LG; Libanio D; Lahner E; Rollan A; Fang JY; Moreira L; Bornschein J; Malfertheiner P; Kuipers EJ; El-Omar EM Gut; 2024 Sep; 73(10):1607-1617. PubMed ID: 39122364 [TBL] [Abstract][Full Text] [Related]
8. AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors. Altayar O; Davitkov P; Shah SC; Gawron AJ; Morgan DR; Turner K; Mustafa RA Gastroenterology; 2020 Feb; 158(3):732-744.e16. PubMed ID: 31816301 [No Abstract] [Full Text] [Related]
9. Update on the Diagnosis and Management of Gastric Intestinal Metaplasia in the USA. Trieu JA; Bilal M; Saraireh H; Wang AY Dig Dis Sci; 2019 May; 64(5):1079-1088. PubMed ID: 30771043 [TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study. Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693 [TBL] [Abstract][Full Text] [Related]
13. Gastric Intestinal Metaplasia: Real Culprit or Innocent Bystander as a Precancerous Condition for Gastric Cancer? Sugano K; Moss SF; Kuipers EJ Gastroenterology; 2023 Dec; 165(6):1352-1366.e1. PubMed ID: 37652306 [TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. Liu KS; Wong IO; Leung WK World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668 [TBL] [Abstract][Full Text] [Related]
15. Low prevalence of gastric intestinal metaplasia and Helicobacter pylori on surveillance upper endoscopy in Lynch syndrome. Pulaski M; Dungan M; Weber M; Constantino G; Katona BW Fam Cancer; 2024 Mar; 23(1):23-27. PubMed ID: 38291131 [TBL] [Abstract][Full Text] [Related]
16. Methylation and Expression of Nonclustered Protocadherins Encoding Genes and Risk of Precancerous Gastric Lesions in a High-Risk Population. Wu S; Zhang Y; Zhang L; Ma JL; Zhou T; Li ZX; Liu WD; Li WQ; You WC; Pan KF Cancer Prev Res (Phila); 2018 Nov; 11(11):717-726. PubMed ID: 30213786 [TBL] [Abstract][Full Text] [Related]
17. From part to whole, operative link on to endoscopic grading of gastric intestinal metaplasia, pathology to endoscopy: gastric intestinal metaplasia graded by endoscopy. Wei N; Zhou M; Lei S; Yang L; Duan Z; Zhang Y; Zhong Z; Liu Y; Shi R Future Oncol; 2022 Jun; 18(19):2445-2454. PubMed ID: 35574611 [No Abstract] [Full Text] [Related]
18. Controlling Gastric Cancer in a World of Heterogeneous Risk. Huang RJ; Laszkowska M; In H; Hwang JH; Epplein M Gastroenterology; 2023 Apr; 164(5):736-751. PubMed ID: 36706842 [TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Chen HN; Wang Z; Li X; Zhou ZG Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452 [TBL] [Abstract][Full Text] [Related]
20. Gastric intestinal metaplasia: subtypes and natural history. El-Zimaity HM; Ramchatesingh J; Saeed MA; Graham DY J Clin Pathol; 2001 Sep; 54(9):679-83. PubMed ID: 11533073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]